Members of the MicroRNA-17-92 Cluster Exhibit a Cell-intrinsic Antiangiogenic Function in Endothelial Cells
Overview
Authors
Affiliations
MicroRNAs are endogenously expressed small noncoding RNAs that regulate gene expression on the posttranscriptional level. The miR-17-92 cluster (encoding miR-17, -18a, -19a/b, -20a, and miR-92a) is highly expressed in tumor cells and is up-regulated by ischemia. Whereas miR-92a was recently identified as negative regulator of angiogenesis, the specific functions of the other members of the cluster are less clear. Here we demonstrate that overexpression of miR-17, -18a, -19a, and -20a significantly inhibited 3-dimensional spheroid sprouting in vitro, whereas inhibition of miR-17, -18a, and -20a augmented endothelial cell sprout formation. Inhibition of miR-17 and miR-20a in vivo using antagomirs significantly increased the number of perfused vessels in Matrigel plugs, whereas antagomirs that specifically target miR-18a and miR-19a were less effective. However, systemic inhibition of miR-17/20 did not affect tumor angiogenesis. Further mechanistic studies showed that miR-17/20 targets several proangiogenic genes. Specifically, Janus kinase 1 was shown to be a direct target of miR-17. In summary, we show that miR-17/20 exhibit a cell-intrinsic antiangiogenic activity in endothelial cells. Inhibition of miR-17/20 specifically augmented neovascularization of Matrigel plugs but did not affect tumor angiogenesis indicating a context-dependent regulation of angiogenesis by miR-17/20 in vivo.
miRNA-6236 Regulation of Postischemic Skeletal Muscle Angiogenesis.
Mani A, Lamin V, Peach R, Friesen E, Wong T, Singh M J Am Heart Assoc. 2024; 13(23):e035923.
PMID: 39604034 PMC: 11681604. DOI: 10.1161/JAHA.124.035923.
The role and mechanism of action of miR‑92a in endothelial cell autophagy.
Cao W, Zhao B, Gui L, Sun X, Zhang Z, Huang L Mol Med Rep. 2024; 30(3).
PMID: 39054957 PMC: 11304162. DOI: 10.3892/mmr.2024.13296.
Mahajan A, Gunewardena S, Morris A, Clauss M, Dhillon N Cells. 2024; 13(11.
PMID: 38891019 PMC: 11172129. DOI: 10.3390/cells13110886.
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies.
Kim T, Croce C Exp Mol Med. 2023; 55(7):1314-1321.
PMID: 37430087 PMC: 10394030. DOI: 10.1038/s12276-023-01050-9.
Potential new therapeutic targets: Association of microRNA with atherosclerotic plaque stability.
Huang P Int J Immunopathol Pharmacol. 2023; 37:3946320231185657.
PMID: 37403558 PMC: 10331098. DOI: 10.1177/03946320231185657.